Cargando…
Myelodysplastic syndrome patients present more severe respiratory muscle impairment and reduced forced vital capacity: Is disordered inflammatory signaling the culprit?
BACKGROUND/OBJECTIVES: The ageing process is associated with gradual decline in respiratory system performance. Anemia is highly prevalent among older adults and usually associated with adverse outcomes. Myelodysplastic syndromes (MDS) are a heterogeneous group of hematologic malignancies with incre...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587331/ https://www.ncbi.nlm.nih.gov/pubmed/28877261 http://dx.doi.org/10.1371/journal.pone.0184079 |
_version_ | 1783261978044661760 |
---|---|
author | Okubo, Bruno Memória de Matos, Anacélia Gomes Ribeiro Junior, Howard Lopes Borges, Daniela de Paula de Oliveira, Roberta Taiane Germano de Castro, Marilena Facundo Martins, Manoel Ricardo Alves Gonçalves, Romélia Pinheiro Bruin, Pedro Felipe Carvalhedo Pinheiro, Ronald Feitosa Magalhães, Silvia Maria Meira |
author_facet | Okubo, Bruno Memória de Matos, Anacélia Gomes Ribeiro Junior, Howard Lopes Borges, Daniela de Paula de Oliveira, Roberta Taiane Germano de Castro, Marilena Facundo Martins, Manoel Ricardo Alves Gonçalves, Romélia Pinheiro Bruin, Pedro Felipe Carvalhedo Pinheiro, Ronald Feitosa Magalhães, Silvia Maria Meira |
author_sort | Okubo, Bruno Memória |
collection | PubMed |
description | BACKGROUND/OBJECTIVES: The ageing process is associated with gradual decline in respiratory system performance. Anemia is highly prevalent among older adults and usually associated with adverse outcomes. Myelodysplastic syndromes (MDS) are a heterogeneous group of hematologic malignancies with increasing incidence with age and characterized by anemia and other cytopenias. The main objectives of this study were to evaluate respiratory muscle strength and lung function in elderly patients with anemia, compare data between myelodysplastic syndromes and non-clonal anemias and evaluate the influence of serum IL-8 level and NF-kB activity on deteriorate pulmonary function in this specific population. PARTICIPANTS: Individuals aged 60 and older with anemia secondary to MDS, non-clonal anemia and healthy elderly individuals. MEASUREMENTS: Forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and FEV1/ FVC ratio were measured by spirometry. Respiratory muscle strength was evaluated by maximal static respiratory pressures measurement. IL-8 analysis was performed by ELISA and activity of NF-kB by chemiluminescent assay. RESULTS: Mean Hb concentration was comparable between patients with anemia. Significant differences were detected between all patients with anemia and controls for maximum-effort inspiratory mouth pressure (PImax) and also for maximum-effort expiratory mouth pressure (PEmax). The MDS group recorded a significantly lower PImax and PEmax percent predicted when compared to non-clonal anemia group. For FVC and FEV1, a significant difference was found in anemic patients, with even significantly lower values for FVC and FEV1 in MDS group. No significant differences were detected for PImax and PEmax and spirometry parameters when anemic patients were stratified according to the degree of anemia. A significant negative impact in FVC (% pred), PImax (% pred) and PEmax (% pred) was observed in patients with MDS and higher levels of IL-8 or increased activity of NF-kB. CONCLUSION: A negative impact of anemia, independent of its degree, was demonstrated in respiratory muscle strength and lung function particularly in MDS. The well known elevated proinflammatory cytokines in MDS patients were proposed to play a role as was demonstrated by detrimental effect of higher IL-8 and NF-kB in pulmonary function tests in this population. |
format | Online Article Text |
id | pubmed-5587331 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-55873312017-09-15 Myelodysplastic syndrome patients present more severe respiratory muscle impairment and reduced forced vital capacity: Is disordered inflammatory signaling the culprit? Okubo, Bruno Memória de Matos, Anacélia Gomes Ribeiro Junior, Howard Lopes Borges, Daniela de Paula de Oliveira, Roberta Taiane Germano de Castro, Marilena Facundo Martins, Manoel Ricardo Alves Gonçalves, Romélia Pinheiro Bruin, Pedro Felipe Carvalhedo Pinheiro, Ronald Feitosa Magalhães, Silvia Maria Meira PLoS One Research Article BACKGROUND/OBJECTIVES: The ageing process is associated with gradual decline in respiratory system performance. Anemia is highly prevalent among older adults and usually associated with adverse outcomes. Myelodysplastic syndromes (MDS) are a heterogeneous group of hematologic malignancies with increasing incidence with age and characterized by anemia and other cytopenias. The main objectives of this study were to evaluate respiratory muscle strength and lung function in elderly patients with anemia, compare data between myelodysplastic syndromes and non-clonal anemias and evaluate the influence of serum IL-8 level and NF-kB activity on deteriorate pulmonary function in this specific population. PARTICIPANTS: Individuals aged 60 and older with anemia secondary to MDS, non-clonal anemia and healthy elderly individuals. MEASUREMENTS: Forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and FEV1/ FVC ratio were measured by spirometry. Respiratory muscle strength was evaluated by maximal static respiratory pressures measurement. IL-8 analysis was performed by ELISA and activity of NF-kB by chemiluminescent assay. RESULTS: Mean Hb concentration was comparable between patients with anemia. Significant differences were detected between all patients with anemia and controls for maximum-effort inspiratory mouth pressure (PImax) and also for maximum-effort expiratory mouth pressure (PEmax). The MDS group recorded a significantly lower PImax and PEmax percent predicted when compared to non-clonal anemia group. For FVC and FEV1, a significant difference was found in anemic patients, with even significantly lower values for FVC and FEV1 in MDS group. No significant differences were detected for PImax and PEmax and spirometry parameters when anemic patients were stratified according to the degree of anemia. A significant negative impact in FVC (% pred), PImax (% pred) and PEmax (% pred) was observed in patients with MDS and higher levels of IL-8 or increased activity of NF-kB. CONCLUSION: A negative impact of anemia, independent of its degree, was demonstrated in respiratory muscle strength and lung function particularly in MDS. The well known elevated proinflammatory cytokines in MDS patients were proposed to play a role as was demonstrated by detrimental effect of higher IL-8 and NF-kB in pulmonary function tests in this population. Public Library of Science 2017-09-06 /pmc/articles/PMC5587331/ /pubmed/28877261 http://dx.doi.org/10.1371/journal.pone.0184079 Text en © 2017 Okubo et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Okubo, Bruno Memória de Matos, Anacélia Gomes Ribeiro Junior, Howard Lopes Borges, Daniela de Paula de Oliveira, Roberta Taiane Germano de Castro, Marilena Facundo Martins, Manoel Ricardo Alves Gonçalves, Romélia Pinheiro Bruin, Pedro Felipe Carvalhedo Pinheiro, Ronald Feitosa Magalhães, Silvia Maria Meira Myelodysplastic syndrome patients present more severe respiratory muscle impairment and reduced forced vital capacity: Is disordered inflammatory signaling the culprit? |
title | Myelodysplastic syndrome patients present more severe respiratory muscle impairment and reduced forced vital capacity: Is disordered inflammatory signaling the culprit? |
title_full | Myelodysplastic syndrome patients present more severe respiratory muscle impairment and reduced forced vital capacity: Is disordered inflammatory signaling the culprit? |
title_fullStr | Myelodysplastic syndrome patients present more severe respiratory muscle impairment and reduced forced vital capacity: Is disordered inflammatory signaling the culprit? |
title_full_unstemmed | Myelodysplastic syndrome patients present more severe respiratory muscle impairment and reduced forced vital capacity: Is disordered inflammatory signaling the culprit? |
title_short | Myelodysplastic syndrome patients present more severe respiratory muscle impairment and reduced forced vital capacity: Is disordered inflammatory signaling the culprit? |
title_sort | myelodysplastic syndrome patients present more severe respiratory muscle impairment and reduced forced vital capacity: is disordered inflammatory signaling the culprit? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587331/ https://www.ncbi.nlm.nih.gov/pubmed/28877261 http://dx.doi.org/10.1371/journal.pone.0184079 |
work_keys_str_mv | AT okubobrunomemoria myelodysplasticsyndromepatientspresentmoresevererespiratorymuscleimpairmentandreducedforcedvitalcapacityisdisorderedinflammatorysignalingtheculprit AT dematosanaceliagomes myelodysplasticsyndromepatientspresentmoresevererespiratorymuscleimpairmentandreducedforcedvitalcapacityisdisorderedinflammatorysignalingtheculprit AT ribeirojuniorhowardlopes myelodysplasticsyndromepatientspresentmoresevererespiratorymuscleimpairmentandreducedforcedvitalcapacityisdisorderedinflammatorysignalingtheculprit AT borgesdanieladepaula myelodysplasticsyndromepatientspresentmoresevererespiratorymuscleimpairmentandreducedforcedvitalcapacityisdisorderedinflammatorysignalingtheculprit AT deoliveirarobertataianegermano myelodysplasticsyndromepatientspresentmoresevererespiratorymuscleimpairmentandreducedforcedvitalcapacityisdisorderedinflammatorysignalingtheculprit AT decastromarilenafacundo myelodysplasticsyndromepatientspresentmoresevererespiratorymuscleimpairmentandreducedforcedvitalcapacityisdisorderedinflammatorysignalingtheculprit AT martinsmanoelricardoalves myelodysplasticsyndromepatientspresentmoresevererespiratorymuscleimpairmentandreducedforcedvitalcapacityisdisorderedinflammatorysignalingtheculprit AT goncalvesromeliapinheiro myelodysplasticsyndromepatientspresentmoresevererespiratorymuscleimpairmentandreducedforcedvitalcapacityisdisorderedinflammatorysignalingtheculprit AT bruinpedrofelipecarvalhedo myelodysplasticsyndromepatientspresentmoresevererespiratorymuscleimpairmentandreducedforcedvitalcapacityisdisorderedinflammatorysignalingtheculprit AT pinheiroronaldfeitosa myelodysplasticsyndromepatientspresentmoresevererespiratorymuscleimpairmentandreducedforcedvitalcapacityisdisorderedinflammatorysignalingtheculprit AT magalhaessilviamariameira myelodysplasticsyndromepatientspresentmoresevererespiratorymuscleimpairmentandreducedforcedvitalcapacityisdisorderedinflammatorysignalingtheculprit |